´
J. M. Concellon et al. / Tetrahedron 60 (2004) 10059–10065
10063
Calcd for C13H17D2NO 207.1466; found 207.1589; Rf 0.2
(hexane/AcOEt 5/1).
MeOH (0.4 mL) were used, respectively, as cosolvent to
carry out the first step.9,10 In the last case, previously to the
addition of CH2I2 and Sm, solvents were eliminated to
dryness.
4.3.6. 2,3-Dideuterio-N,N-diethyl-3-[4-(methoxy)phe-
1
nyl]propanamide (3b). H NMR (300 MHz, CDCl3): dZ
In the obtention of 8a, cyclopropanation took place at 0 8C,
during 2 h and just with 1.4 mmol of samarium powder and
1.4 mmol of CH2I2.
7.14 (d, JZ8.7 Hz, 2H), 6.83 (d, JZ8.7 Hz, 2H), 3.78 (s,
3H), 3.37 (q, JZ7.2 Hz, 2H), 3.21 (q, JZ7.2 Hz, 2H), 2.98–
2.78 (m, 1H), 2.62–2.44 (m, 1H), 1.11 (t, JZ7.2 Hz, 3H),
1.10 (t, JZ7.2 Hz, 3H); 13C NMR (50 MHz, CDCl3): dZ
171.2 (C), 157.8 (C), 133.4 (C), 129.2 (CH), 113.7 (CH),
55.1 (CH3), 41.7 (CH2), 40.0 (CH2), 34.8 (CHD, t, JZ
19.2 Hz), 30.2 (CHD, t, JZ19.2 Hz), 14.1 (CH3), 12.9
(CH3); MS (70 eV): m/z (%): 227 (2) [M]C, 222 (2), 147
(35), 72 (100); IR 3060, 1636, 1514, 1458 cmK1; Rf 0.3
(hexane/AcOEt 3/1).
4.4.1. (1S*,2S*)-N,N-Diethyl-2-phenylcyclopropanocar-
boxamide (8a). 1H NMR (300 MHz, CDCl3): dZ7.31–
7.10 (m, 5H), 3.44 (q, JZ7.18 Hz, 2H), 3.43 (q, JZ7.18 Hz,
2H), 2.49 (ddd, JZ9.11, 5.98, 4.27 Hz, 1H), 1.93 (ddd, JZ
8.25, 5.41, 4.27 Hz, 1H), 1.65 (ddd, JZ9.11, 5.41, 3.99 Hz,
1H), 1.25 (ddd, JZ8.25, 5.98, 3.99 Hz, 1H), 1.19 (t, JZ
7.18 Hz, 3H), 1.14 (t, JZ7.18 Hz, 3H); 13C NMR (75 MHz,
CDCl3): dZ170.9 (C), 141.0 (C), 128.3 (CH), 126.0 (CH),
42.0 (CH2), 40.8 (CH2), 25.3 (CH), 23.1 (CH), 16.1 (CH2),
14.8 (CH3), 13.2 (CH3); MS (70 eV): m/z (%): 217 (37)
[M]C, 145 (25), 117 (39), 72 (91), 42 (100); IR 3019, 2971,
1627, 1452, 1377 cmK1; HRMS Calcd for C14H19NO
217.1467; found 217.1495; Rf 0.3 (hexane/AcOEt 3/1).
4.3.7. 2,3-Dideuterio-N,N-diethyl-2-phenylheptanamide
1
(3c). H NMR (200 MHz, CDCl3): dZ7.39–7.19 (m, 5H),
3.56–3.06 (m, 4H), 2.18–1.53 (m, 2H), 1.49–1.10 (m, 5H),
1.17–0.78 (m, 9H); 13C NMR (50 MHz, CDCl3): dZ172.1
(C), 140.8 (C), 128.5 (CH), 127.7 (CH), 126.5 (CH), 48.3
(CD, t, JZ19.4 Hz), 41.5 (CH2), 40.3 (CH2), 34.9 (CHD, t,
JZ19.4 Hz), 31.7 (CH2), 27.4 (CH2), 22.4 (CH2), 14.4
(CH3), 13.9 (CH3), 12.8 (CH3); IR 2939, 1636, 1456,
1380 cmK1. Anal. Calcd for C17H25D2NO: C, 74.61; H,
11.10; N, 5.32; found: C, 74.60; H, 10.09; N, 5.39; Rf 0.3
(hexane/AcOEt 3/1).
4.4.2. (1S*,2R*)-2-Cyclohexyl-N,N-diethyl-1-methyl-
cyclopropanocarboxamide (8d). 1H NMR (400 MHz,
[D6]DMSO): dZ3.48 (q, JZ7.05 Hz, 4H), 1.95–1.69 (m,
5H), 1.45–0.98 (m, 6H), 1.33 (s, 3H), 1.17 (t, JZ7.05 Hz,
6H), 1.06 (dd, JZ8.97, 4.20 Hz, 1H), 0.90 (dd, JZ8.97,
4.77 Hz, 1H), 0.27 (dd, JZ4.77, 4.20 Hz, 1H); 13C NMR
(100 MHz, [D6]DMSO): dZ172.7 (C), 39.1 (CH2), 36.9
(CH), 32.2 (CH2), 27.8 (CH), 25.5 (CH2), 25.3 (CH2), 25.1
(CH2), 24.5 (C), 16.9 (CH2), 15.7 (CH3), 12.6 (CH3); MS
(70 eV): m/z (%): 237 (10) [M]C, 222 (5), 100 (25), 55 (52),
41 (100); IR 2981, 2924, 1627, 1429, 1379 cmK1; HRMS
Cald. for C15H27NO 237.2093 found 237.2101; Rf 0.4
(hexane/AcOEt 3/1).
4.3.8. 2,3-Dideuterio-N,N-diethyl-3-phenyl-2-methyl-
propanamide (3f). (Diastereoisomeric mixture); H NMR
1
(300 MHz, CDCl3): dZ7.30–7.15 (m, 10H), 3.48–3.36 (m,
2H), 3.25–3.13 (m, 2H), 3.05 (q, JZ7.18 Hz, 4H), 2.62 (s,
2H), 1.26 (s, 3H), 1.16 (s, 3H), 1.02 (t, JZ7.18 Hz, 6H),
0.93 (t, JZ7.18 Hz, 6H); 13C NMR (75 MHz, CDCl3): dZ
175.0 (C), 140.6 (C), 140.1 (C), 129.0 (CH), 128.9 (CH),
128.1 (CH), 126.0 (CH), 125.7 (CH), 41.6 (CH2), 40.3
(CH2), 40.3 (t, JZ19.8 Hz, CHD), 37.6 (t, JZ19.8 Hz, CD),
18.0 (CH3), 14.5 (CH3), 12.9 (CH3); MS (70 eV): m/z (%):
221 (36) [M]C, 206 (22), 121 (19), 92 (100); IR 3062, 3026,
2971, 1636, 1379 cmK1; HRMS Calcd for C14H19D2NO
221.1735; found 221.1749; Rf 0.3 (hexane/AcOEt 3/1).
4.4.3. (1S*,2S*)-N,N-Diethyl-2-heptyl-1-methylcyclo-
propanocarboxamide (8e). H NMR (200 MHz, CDCl3):
1
dZ3.59–3.19 (m, 4H), 1.60–0.95 (m, 17H), 1.20 (s, 3H),
1.09 (t, JZ7.12 Hz, 3H), 0.83 (t, JZ6.55 Hz, 3H), 0.13 (dd,
JZ5.41, 4. 84 Hz, 1H); 13C RMN (50 MHz, CDCl3): dZ
174.5 (C), 40.8 (CH2), 40.1 (CH2), 31.7 (CH2), 29.4 (CH2),
29.3 (CH2), 29.2 (CH2), 24.4 (C), 22.6 (CH2), 22.3 (CH),
18.5 (CH2), 16.4 (CH3), 14.3 (CH3), 14.0 (CH3), 13.6
(CH3); MS (70 eV): m/z (%): 253 (18) [M]C, 238 (10), 154
4.4. General procedure for the synthesis of compounds 8
Over a solution of SmI2 (1.1 mmol for di- or tetrasubstituted
aromatic 2,3-epoxyamides 1 and 1.7 mmol for the rest) in
THF (12 and 20 mL, respectively), a solution of the
corresponding 2,3-epoxyamide 1 (0.4 mmol) in THF
(4 mL) was added, under nitrogen atmosphere, at room
temperature. After stirring for 30 min, the complete
formation of 5 was checked by TLC. Then, when samarium
diiodide remained, iodine pearls were added till colour
changed from blue to yellow. The reaction mixture was
cooled to K30 8C and 16 mL of dry THF, 2.4 mmol of
samarium powder and 2.4 mmol of CH2I2 were added. After
stirring at K30 8C during 10 h, the excess samarium
diiodide was destroyed by oxidation with air, and the
reaction was quenched with aqueous HCl (0.1 M, 10 mL).
Usual workup afforded crude cyclopropanamides 8, which
were purified by short column flash chromatography over
silica gel (hexane/ethyl acetate 3:1).
(18), 100 (81), 41 (100); IR 2929, 1626, 1425, 1377 cmK1
;
HRMS Calcd for C16H31NO 253.2406; found 253.2406; Rf
0.4 (hexane/AcOEt 3/1).
4.4.4. (1R*,2S*)-N,N-Diethyl-1-methyl-2-phenylcyclo-
propanocarboxamide (8f). H NMR (300 MHz, CDCl3):
1
dZ7.28–7.03 (m, 5H), 3.48–3.33 (m, 2H), 2.96–2.87 (m,
1H), 2.74–2.87 (m, 1H), 2.16 (dd, JZ5.6, 8.8 Hz, 1H), 2.10
(dd, JZ6.5, 8.8 Hz, 1H), 1.73 (aparent t, JZ6.0 Hz, 1H),
1.45 (s, 3H), 0.76 (t, JZ7.1 Hz, 6H); 13C RMN (75 MHz,
CDCl3): dZ170.5 (C), 138.6 (C), 127.9 (CH), 126.3 (CH),
125.8 (CH), 40.4 (CH2), 38.2 (CH2), 31.7 (CH), 31.5 (C),
23.3 (CH3), 19.5 (CH2), 13.2 (CH3), 11.8 (CH3); MS
(70 eV): m/z (%): 231 (64) [M]C, 216 (12), 202 (5), 158
(32), 144 (11), 140 (26), 131 (46), 115 (38), 100 (72), 91
(100), 72 (82); IR 3062, 2975, 2931, 2878, 1632, 1461,
In the case of synthesis of 8b,c or 8d,e, HMPA (0.5 mL) or